1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Diabetic Foot Ulcer Therapeutics - Introduction 2.1 Overview Diabetic Foot Ulcer

Transcription

1 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Diabetic Foot Ulcer Therapeutics - Introduction 2.1 Overview Diabetic Foot Ulcer Classification Systems 2.2 Epidemiology Historic Epidemiology (2006-) Forecast Epidemiology (-) 2.3 Prognosis 2.4 Etiology 2.5 Symptoms 2.6 Diagnosis History Neurologic Examination Vascular Examination Musculoskeletal Examination Wound Evaluation Laboratory Testing and Imaging Studies 2.7 Pathophysiology 2.8 Treatment and Management Pattern Infection Control Mechanical Load Relief Wound Care/Debridement Blood Glucose Control Patient Education 2.9 Referral Pathway 2.10 GlobalData Pipeline Report Guidance 3 Diabetic Foot Ulcer Therapeutics - Market Characterization 3.1 Diabetic Foot Ulcer Therapeutics Market Size (2006-) - Global 3.2 Diabetic Foot Ulcer Therapeutics Market Forecast (-) - Global 3.3 Diabetic Foot Ulcer Therapeutics Market Size (2006-) - The US 3.4 Diabetic Foot Ulcer Therapeutics Market Forecast (-) - The US 3.5 Diabetic Foot Ulcer Therapeutics Market Size (2006-) - France 3.6 Diabetic Foot Ulcer Therapeutics Market Forecast (-) - France 3.7 Diabetic Foot Ulcer Therapeutics Market Size (2006-) - Germany 3.8 Diabetic Foot Ulcer Therapeutics Market Forecast (-) - Germany 3.9 Diabetic Foot Ulcer Therapeutics Market Size (2006-) - Italy 3.10 Diabetic Foot Ulcer Therapeutics Market Forecast (-) - Italy 3.11 Diabetic Foot Ulcer Therapeutics Market Size (2006-) - Spain 3.12 Diabetic Foot Ulcer Therapeutics Market Forecast (-) - Spain 3.13 Diabetic Foot Ulcer Therapeutics Market Size (2006-) - The UK 3.14 Diabetic Foot Ulcer Therapeutics Market Forecast (-) - The UK 3.15 Diabetic Foot Ulcer Therapeutics Market Size (2006-) - Japan 3.16 Diabetic Foot Ulcer Therapeutics Market Forecast (-) - Japan 3.17 Drivers and Barriers for the Diabetic Foot Ulcer Therapeutics Market

2 Drivers of the Diabetic Foot Ulcer Therapeutics Market Barriers for the Diabetic Foot Ulcer Therapeutics Market 3.18 Opportunity and Unmet Need 3.19 Key Takeaway 4 Diabetic Foot Ulcer Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles for the Major Marketed Products in the Diabetic Foot Ulcer Therapeutics Market 4.4 Anti-infectives Invanz (ertapenem) Zosyn (piperacillin/tazobactam) Zyvox (linezolid) 4.5 Wound-healing Products Regranex (becaplermin) 4.6 Key Takeaway 5 Diabetic Foot Ulcer Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Diabetic Foot Ulcer Therapeutics - Pipeline Analysis by Phase of Development Diabetic Foot Ulcer Therapeutics - Phase III Pipeline Diabetic Foot Ulcer Therapeutics - Phase II Pipeline Diabetic Foot Ulcer Therapeutics - Phase I Pipeline Diabetic Foot Ulcer Therapeutics - Preclinical and Discovery Pipeline 5.4 Diabetic Foot Ulcer Therapeutics - Pipeline by Mechanism of Action 5.5 Technology Trends Analytical Framework 5.6 Profiles of Promising Drugs CVBT-141B (FGF-1) Fragmin (dalteparin sodium) Trafermin Heberprot-P HO/03/ CureXcell 5.7 Key Takeaway 6 Diabetic Foot Ulcer Therapeutics - Clinical Trial Mapping 6.1 Clinical Trials by Region and Country 6.2 Clinical Trials by Phase of Clinical Development 6.3 Clinical Trials by Trial Status 6.4 Clinical Trials by Sponsors 6.5 Top Companies Participating in Diabetic Foot Ulcer Therapeutics Clinical Trials 7 Diabetic Foot Ulcer Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Future Market Competition Scenario 8 Diabetic Foot Ulcer Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles

3 8.2.1 Pfizer Inc Cardiovascular Biotherapeutics, Inc HealOr Ltd MacroCure Ltd Other Companies in the Pipeline 9 Diabetic Foot Ulcer Therapeutics - Licensing and Partnership Deals 10 Diabetic Foot Ulcer Therapeutics - Appendix 10.1 Market Definitions 10.2 Abbreviations 10.3 Bibliography 10.4 Physicians and Specialists Included in this Study 10.5 Research Methodology Coverage Secondary Research Forecasting Primary Research Expert Panel Validation 10.6 Contact Us 10.7 Disclaimer 1.1 List of Tables Table 1: Diabetic Foot Ulcer - Wagner-Meggitt Classification Table 2: The University of Texas - Diabetic Wound Classification System Table 3: Diabetic Foot Ulcer, Global, Prevalence Population, Table 4: Diabetic Foot Ulcer, Global, Prevalence Population, - Table 5: Diabetic Foot Ulcer - Risk Factors Table 6: Diabetic Foot Infections - Empirical Antibiotic Regimens Table 7: Diabetic Foot Infection Therapeutics Market, Global, Revenue ($m), Table 8: Wound-healing Therapeutics Market, Global, Revenue ($m), Table 9: Diabetic Foot Infection Therapeutics Market, Global, Forecast ($m), - Table 10: Wound-healing Therapeutics Market, Global, Forecast ($m), - Table 11: Diabetic Foot Infection Therapeutics Market, The US, Revenue ($m), Table 12: Wound-healing Therapeutics Market, The US, Revenue ($m), Table 13: Diabetic Foot Infection Therapeutics Market, The US, Forecast ($m), - Table 14: Wound-healing Therapeutics Market, The US, Forecast ($m), - Table 15: Diabetic Foot Infection Therapeutics Market, France, Revenue ($m), Table 16: Wound-healing Therapeutics Market, France, Revenue ($m), Table 17: Diabetic Foot Infection Therapeutics Market, France, Forecast ($m), - Table 18: Wound-healing Therapeutics Market, France, Forecast ($m), - Table 19: Diabetic Foot Infection Therapeutics Market, Germany, Revenue ($m), Table 20: Wound-healing Therapeutics Market, Germany, Revenue ($m), 2006-

4 Table 21: Diabetic Foot Infection Therapeutics Market, Germany, Forecast ($m), - Table 22: Wound-healing Therapeutics Market, Germany, Forecast ($m), - Table 23: Diabetic Foot Infection Therapeutics Market, Italy, Revenue ($m), Table 24: Wound-healing Therapeutics Market, Italy, Revenue ($m), Table 25: Diabetic Foot Infection Therapeutics Market, Italy, Forecast ($m), - Table 26: Wound-healing Therapeutics Market, Italy, Forecast ($m), - Table 27: Diabetic Foot Infection Therapeutics Market, Spain, Revenue ($m), Table 28: Wound-healing Therapeutics Market, Spain, Revenue ($m), Table 29: Diabetic Foot Infection Therapeutics Market, Spain, Forecast ($m), - Table 30: Wound-healing Therapeutics Market, Spain, Forecast ($m), - Table 31: Diabetic Foot Infection Therapeutics Market, The UK, Revenue ($m), Table 32: Wound-healing Therapeutics Market, The UK, Revenue ($m), Table 33: Diabetic Foot Infection Therapeutics Market, The UK, Forecast ($m), - Table 34: Wound-healing Therapeutics Market, The UK, Forecast ($m), - Table 35: Diabetic Foot Infection Therapeutics Market, Japan, Revenue ($m), Table 36: Wound-healing Therapeutics Market, Japan, Revenue ($m), Table 37: Diabetic Foot Infection Therapeutics Market, Japan, Forecast ($m), - Table 38: Wound-healing Therapeutics Market, Japan, Forecast ($m), - Table 39: Diabetic Foot Ulcer Therapeutics - Phase III Pipeline, 2012 Table 40: Diabetic Foot Ulcer Therapeutics - Phase II Pipeline, 2012 Table 41: Diabetic Foot Ulcer Therapeutics - Phase I Pipeline, 2012 Table 42: Diabetic Foot Ulcer Therapeutics - Preclinical and Discovery Pipeline, 2012 Table 43: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials, 2012 Table 44: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Phase, 2012 Table 45: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Status of Development, 2012 Table 46: Diabetic Foot Ulcer Therapeutics, Global, Overall Sponsors, 2012 Table 47: Diabetic Foot Ulcer Therapeutics, Global, Prominent Sponsors, 2012 Table 48: Diabetic Foot Ulcer Therapeutics, Global, Top Ten Companies by Phase, 2012 Table 49: Pfizer, Inc. - Diabetic Foot Ulcer Pipeline Products, 2012 Table 50: Cardiovascular Biotherapeutics, Inc. - DFU Pipeline Products, 2012 Table 51: HealOr Ltd. - DFU Pipeline Products, 2012 Table 52: MacroCure Ltd. - DFU Pipeline Products, 2012 Table 53: Diabetic Foot Ulcer Therapeutics - Other Companies in the Pipeline, 2012 Table 54: Diabetic Foot Ulcer Therapeutics, Licensing and Partnership Deals, List of Figures Figure 1: The University of Texas - Diabetic Wound Classification System Figure 2: Diabetic Foot Ulcer - Pathophysiology Figure 3: Diabetic Foot Infections - Antibiotic Use According to Clinical Severity Figure 4: Diabetic Foot Ulcer - Referral Pathway Figure 5: Diabetic Foot Infection Therapeutics Market, Global, Revenue ($m), Figure 6: Wound-healing Therapeutics Market, Global, Revenue ($m), 2006-

5 Figure 7: Diabetic Foot Infection Therapeutics Market, Global, Forecast ($m), - Figure 8: Wound-healing Therapeutics Market, Global, Forecast ($m), - Figure 9: Diabetic Foot Infection Therapeutics Market, The US, Revenue ($m), Figure 10: Wound-healing Therapeutics Market, The US, Revenue ($m), Figure 11: Diabetic Foot Infection Therapeutics Market, The US, Forecast ($m), - Figure 12: Wound-healing Therapeutics Market, The US, Forecast ($m), - Figure 13: Diabetic Foot Infection Therapeutics Market, France, Revenue ($m), Figure 14: Wound-healing Therapeutics Market, France, Revenue ($m), Figure 15: Diabetic Foot Infection Therapeutics Market, France, Forecast ($m), - Figure 16: Wound-healing Therapeutics Market, France, Forecast ($m), - Figure 17: Diabetic Foot Infection Therapeutics Market, Germany, Revenue ($m), Figure 18: Wound-healing Therapeutics Market, Germany, Revenue ($m), Figure 19: Diabetic Foot Infection Therapeutics Market, Germany, Forecast ($m), - Figure 20: Wound-healing Therapeutics Market, Germany, Forecast ($m), - Figure 21: Diabetic Foot Infection Therapeutics Market, Italy, Revenue ($m), Figure 22: Wound-healing Therapeutics Market, Italy, Revenue ($m), Figure 23: Diabetic Foot Infection Therapeutics Market, Italy, Forecast ($m), - Figure 24: Wound-healing Therapeutics Market, Italy, Forecast ($m), - Figure 25: Diabetic Foot Infection Therapeutics Market, Spain, Revenue ($m), Figure 26: Wound-healing Therapeutics Market, Spain, Revenue ($m), Figure 27: Diabetic Foot Infection Therapeutics Market, Spain, Forecast ($m), - Figure 28: Wound-healing Therapeutics Market, Spain, Forecast ($m), - Figure 29: Diabetic Foot Infection Therapeutics Market, The UK, Revenue ($m), Figure 30: Wound-healing Therapeutics Market, The UK, Revenue ($m), Figure 31: Diabetic Foot Infection Therapeutics Market, The UK, Forecast ($m), - Figure 32: Wound-healing Therapeutics Market, The UK, Forecast ($m), - Figure 33: Diabetic Foot Infection Therapeutics Market, Japan, Revenue ($m), Figure 34: Wound-healing Therapeutics Market, Japan, Revenue ($m), Figure 35: Diabetic Foot Infection Therapeutics Market, Japan, Forecast ($m), - Figure 36: Wound-healing Therapeutics Market, Japan, Forecast ($m), - Figure 37: Diabetic Foot Ulcer Therapeutics Market, Drivers and Barriers, 2012 Figure 38: Opportunity and Unmet Need in Diabetic Foot Infection Therapeutics Market, 2012 Figure 39: Opportunity and Unmet Need in the Diabetic Foot Ulcer Wound-healing Therapeutics Market, 2012

6 Figure 40: Strategic Competitor Assessment of the Marketed Products in Diabetic Foot Ulcer Therapeutics, 2012 Figure 41: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Mechanism of Action (%), 2012 Figure 42: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Phase of Development (%), 2012 Figure 43: Technology Trends Analytics Framework, 2012 Figure 44: Technology Trends Analytics Framework - Description, 2012 Figure 45: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Country, 2012 Figure 46: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Phase (%), 2012 Figure 47: Diabetic Foot Ulcer Therapeutics, Global, Clinical Trials by Status of Development (%), 2012 Figure 48: Diabetic Foot Ulcer Therapeutics, Global, Overall Sponsors (%), 2012 Figure 49: Diabetic Foot Ulcer Therapeutics, Global, Prominent Sponsors (%), 2012 Figure 50: Diabetic Foot Ulcer Therapeutics, Global, Top Companies by Phase, 2012 Figure 51: Diabetic Foot Ulcer Therapeutics Market, Impact Analysis, 2012 Figure 52: Implications for Future Market Competition in the Diabetic Foot Ulcer Therapeutics Market, 2012 Figure 53: Diabetic Foot Ulcer Therapeutics, Clinical Pipeline by Company, 2012 Figure 54: GlobalData Market Size Estimation Figure 55: GlobalData Market Forecasting Model